Lupin gets USFDA nod to marketplace accepted model of Sulfamethoxazole and Trimethoprim

Lupin gets USFDA nod to marketplace accepted model of Sulfamethoxazole and Trimethoprim

by admin- Thursday, January 7th, 2021 04:28:47 PM

Lupin obtained acclaim for its Sulfamethoxazole and Trimethoprim Oral Suspension USP, 200 mg/40 mg consistent with five mL, from the US Food and Drug Administration, to market a frequent equal of Bactrim Oral Suspension, 200 mg/forty mg consistent with five mL, of Sun Pharmaceutical Industries, Inc.

Sulfamethoxazole and Trimethoprim Oral Suspension USP, 2 hundred mg/forty mg in keeping with five mL, is indicated for the treatment and prevention of a huge form of bacterial infections (along with middle ear, urine, respiratory, and intestinal infections), and certain kind of pneumonia (pneumocystis-kind).

News Updates